ID: ALA4777707

Max Phase: Preclinical

Molecular Formula: C25H48N4O12

Molecular Weight: 596.67

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCC(=O)NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C25H48N4O12/c1-2-3-4-5-6-14(31)29-8-12-17(33)19(35)20(36)25(38-12)41-23-11(27)7-10(26)22(21(23)37)40-24-18(34)15(28)16(32)13(9-30)39-24/h10-13,15-25,30,32-37H,2-9,26-28H2,1H3,(H,29,31)/t10-,11+,12-,13-,15+,16-,17-,18-,19+,20-,21-,22+,23-,24-,25-/m1/s1

Standard InChI Key:  XMGMIMSZBLPQCW-SLBGISSRSA-N

Associated Targets(Human)

Gap junction beta-2 protein 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gap junction alpha-1 protein 92 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 596.67Molecular Weight (Monoisotopic): 596.3269AlogP: -5.16#Rotatable Bonds: 12
Polar Surface Area: 285.69Molecular Species: BASEHBA: 15HBD: 11
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.05CX Basic pKa: 9.34CX LogP: -4.76CX LogD: -8.50
Aromatic Rings: 0Heavy Atoms: 41QED Weighted: 0.09Np Likeness Score: 1.08

References

1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT.  (2020)  Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels.,  203  [PMID:32679454] [10.1016/j.ejmech.2020.112602]

Source